Johnson & Johnson at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
Johnson & Johnson takes part in 2 sessions at Cell 2026 in London. Its sessions centre on the business side of cell and gene therapy, including where large drugmakers stand and what comes next. It also takes on the hurdles of commercialising these therapies in global markets.
| Organization | Cell 2026 Attendance |
|---|---|
Johnson & Johnson New Brunswick, New Jersey | |
Healthcare group whose Innovative Medicine arm, formerly Janssen, markets drugs including a CAR-T cell therapy for multiple myeloma. | Panel Thu Nov 12 2:40pm–3:05pm Where Does Big Pharma Stand In CGTs – And What Comes Next? Cell and gene therapy Panel Thu Nov 12 4:55pm–5:20pm |
Instantly find 20 buyers from Johnson & Johnson
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction